TG Therapeutics ( (TGTX) ) has released its Q4 earnings. Here is a breakdown of the information TG Therapeutics presented to its investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of novel treatments for B-cell diseases, with a focus on multiple sclerosis therapies.